MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Matrin 3 (MATR3) is a nuclear protein crucial for RNA processing.
• Missense mutations in the MATR3 gene are associated with familial amyotrophic lateral sclerosis (ALS) and distal myopathy.
• The precise role of MATR3 mutations in disease pathogenesis remains unclear.

Purpose of the Study:

• To investigate the in vivo pathogenic role of a specific MATR3 mutation linked to familial ALS.
• To generate and characterize a CRISPR/Cas9 knock-in mouse model expressing the MATR3 P154S variant.

Main Methods:

• CRISPR/Cas9 gene editing was used to create knock-in mice harboring the MATR3 P154S mutation.
• Endogenous promoter controlled expression of the mutant MATR3 gene.
• Phenotypic analysis included assessment of motor function and neuropathological examination in heterozygous and homozygous mice.

Main Results:

• MATR3 P154S knock-in mice (heterozygous and homozygous) did not exhibit progressive motor deficits compared to wild-type controls.
• No ALS-like pathology was observed in the nervous or muscle tissues of the mutant mice.
• The P154S variant alone did not appear sufficient to induce disease phenotypes in this model.

Conclusions:

• The MATR3 P154S mutation is not sufficient to cause amyotrophic lateral sclerosis-like pathology or motor neuron dysfunction in vivo.
• This study provides crucial insights into the complex genetic factors underlying ALS pathogenesis.
• Further research is needed to elucidate the full spectrum of MATR3's role in neurological diseases.